QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 258 filers reported holding QIAGEN NV in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,605 | +0.1% | 89 | +11.2% | 0.00% | – |
Q2 2023 | $3,602 | -59.6% | 80 | -58.8% | 0.00% | – |
Q1 2023 | $8,910 | +16.8% | 194 | +26.8% | 0.00% | – |
Q4 2022 | $7,630 | +281.5% | 153 | +200.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 51 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | -60.0% | 51 | -48.0% | 0.00% | – |
Q4 2021 | $5,000 | +400.0% | 98 | +237.9% | 0.00% | – |
Q1 2021 | $1,000 | -50.0% | 29 | -12.1% | 0.00% | – |
Q4 2020 | $2,000 | – | 33 | +725.0% | 0.00% | – |
Q3 2020 | $0 | – | 4 | 0.0% | 0.00% | – |
Q2 2020 | $0 | -100.0% | 4 | -87.9% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 33 | -42.1% | 0.00% | – |
Q4 2019 | $2,000 | -77.8% | 57 | -78.9% | 0.00% | – |
Q3 2019 | $9,000 | +350.0% | 270 | +373.7% | 0.00% | – |
Q2 2019 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
Q1 2019 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
Q4 2018 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
Q3 2018 | $2,000 | 0.0% | 57 | 0.0% | 0.00% | – |
Q2 2018 | $2,000 | – | 57 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Hardman Johnston Global Advisors LLC | 4,177,260 | $158,235,000 | 6.82% |
Exane Asset Management | 522,037 | $19,742,931,000 | 6.18% |
Tikvah Management LLC | 442,942 | $16,779,000 | 5.01% |
Opus Point Partners Management, LLC | 31,620 | $1,198,000 | 2.86% |
EDMOND DE ROTHSCHILD HOLDING S.A. | 2,600,672 | $98,144,000 | 2.79% |
RTW INVESTMENTS, LP | 775,324 | $29,369,000 | 1.76% |
SANDLER CAPITAL MANAGEMENT | 787,529 | $29,832,000 | 1.51% |
FRIESS ASSOCIATES LLC | 531,900 | $20,148,000 | 1.40% |
Sivik Global Healthcare LLC | 85,000 | $3,220,000 | 1.15% |
Parametrica Management Ltd | 11,940 | $452,000 | 0.99% |